Cited by 495Alzheimer's disease research and treatmentsGenomics and Chromatin DynamicsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index; 12 of the 26 sources its claims cite were checked for support.

Tau promotes neurodegeneration through global chromatin relaxation

Open access
Frost, Bess, Hemberg, Martin, Lewis, Jada, Feany, Mel B·2014·Nature Neuroscience

Abstract

The microtubule-associated protein tau is involved in a number of neurodegenerative disorders, including Alzheimer's disease. Previous studies have linked oxidative stress and subsequent DNA damage to neuronal death in Alzheimer's disease and related tauopathies. Given that DNA damage can substantially alter chromatin structure, we examined epigenetic changes in tau-induced neurodegeneration. We found widespread loss of heterochromatin in tau transgenic Drosophila and mice and in human Alzheimer's disease. Notably, genetic rescue of tau-induced heterochromatin loss substantially reduced neurodegeneration in Drosophila. We identified oxidative stress and subsequent DNA damage as a mechanistic link between transgenic tau expression and heterochromatin relaxation, and found that heterochromatin loss permitted aberrant gene expression in tauopathies. Furthermore, large-scale analyses from the brains of individuals with Alzheimer's disease revealed a widespread transcriptional increase in genes that were heterochromatically silenced in controls. Our results establish heterochromatin loss as a toxic effector of tau-induced neurodegeneration and identify chromatin structure as a potential therapeutic target in Alzheimer's disease.

Overview

Integrity signals

Registry

Crossref · 10.1038/nn.3639

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

61 Own result · 33 Own interpretation · 15 Own method · 5 No full text of the sources · 4 Partly supported · 3 Supported · 3 No basis given · 2 Supported so far · 2 Sources not found · accuracy not yet measured

Show all 88 claims

  • It may state two separate claims as one. 19
  • Probably not a substantial claim. 25
  • The quote only partly states this claim. 1
40 of 40
  • The paper relies on this without support.

    The human AD postmortem brain samples and controls are representative of AD and non-demented controls, respectively, and differ only in AD-related pathology.

    “We next used quantitative methods to validate the loss of H3K9me2 and increase of PIWIL1 levels in AD in age-, gender-, and postmortem interval-matched cases and controls.”
  • The paper relies on this without support.

    The fetal brain gene expression profile is a valid reference for a dedifferentiated state.

    “We compared gene expression profiles of fetal brains, human control hippocampal neurons, hippocampal neurons from AD, and whole hippocampal tissue from control and three stages of AD.”
  • The paper relies on this without support.

    Ago3 is homologous to the human gene PIWIL1.

    “Ago3 is homologous to the human gene PIWIL1”
  • The paper relies on this without support.

    CG15661 is homologous to the human gene UGT1A10.

    “CG15661 is homologous to the human gene UGT1A10.”
  • The paper relies on this without support.

    Variance is similar between groups that are being compared.

    “Variance is similar between groups that are being compared.”
  • The authors state this as an assumption.

    Data distribution is normal (except for ChIP-seq analysis).

    “Data distribution was assumed to be normal but this was not formally tested except for ChIP-seq analysis.”
  • The paper relies on this without support.

    The simple external exoskeleton structure of the fly results in head preparations composed of primarily nervous system tissue.

    “the simple external exoskeleton structure of the fly results in head preparations composed of primarily nervous system tissue.”
7 of 7

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Cited by

Sorted by citations

See all 495

Metadata

Authors
Frost, B., Hemberg, M., Lewis, J., & Feany, M. B.
Affiliations
  • Brigham and Women's Hospital (US)
  • Boston Children's Hospital (US)
  • University of Florida (US)
Venue
Nature Neuroscience
Published
2014-01-26
Volume
17
Issue
3
Pages
357-366
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2006588853
Cited by
495
References
61
Citations by year
2026: 41 · 2025: 38 · 2024: 42 · 2023: 48 · 2022: 52 · 2021: 48 · 2020: 43 · 2019: 31 · 2018: 41 · 2017: 36 · 2016: 28 · 2015: 30 · 2014: 16
FWCI
13.46
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • National Institute on Aging (R01AG044113, R01AG033518, F32AG039193)
  • National Cancer Institute (P01CA095616)
  • National Institute of General Medical Sciences (R01GM084947)
  • National Institute of Neurological Disorders and Stroke (U24NS050606, R21NS070250)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
tau protein, neurodegeneration, heterochromatin loss, chromatin relaxation, Alzheimer's disease, tauopathy, oxidative stress, DNA damage, epigenetic modifications, aberrant gene expression, therapeutic target
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Drosophila melanogaster, Female, Heterochromatin, Humans, Male, Mice, Inbred C57BL, Nerve Degeneration, tau Proteins, Tauopathies, Animals, Genetically Modified, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review